304 related articles for article (PubMed ID: 2790194)
1. Increased plasma levels of interleukin-6 in sepsis.
Hack CE; De Groot ER; Felt-Bersma RJ; Nuijens JH; Strack Van Schijndel RJ; Eerenberg-Belmer AJ; Thijs LG; Aarden LA
Blood; 1989 Oct; 74(5):1704-10. PubMed ID: 2790194
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
[TBL] [Abstract][Full Text] [Related]
3. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
Dofferhoff AS; de Jong HJ; Bom VJ; van der Meer J; Limburg PC; de Vries-Hospers HG; Marrink J; Mulder PO; Weits J
Scand J Infect Dis; 1992; 24(2):197-204. PubMed ID: 1641597
[TBL] [Abstract][Full Text] [Related]
4. A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients.
Hack CE; Nuijens JH; Strack van Schijndel RJ; Abbink JJ; Eerenberg AJ; Thijs LG
Intensive Care Med; 1990; 16 Suppl 3():S187-91. PubMed ID: 2289988
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8 in sepsis: relation to shock and inflammatory mediators.
Hack CE; Hart M; van Schijndel RJ; Eerenberg AJ; Nuijens JH; Thijs LG; Aarden LA
Infect Immun; 1992 Jul; 60(7):2835-42. PubMed ID: 1612748
[TBL] [Abstract][Full Text] [Related]
6. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
[TBL] [Abstract][Full Text] [Related]
7. The hemodynamics of human septic shock relate to circulating innate immunity factors.
Hartemink KJ; Groeneveld AB
Immunol Invest; 2010; 39(8):849-62. PubMed ID: 20718660
[TBL] [Abstract][Full Text] [Related]
8. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.
Dofferhoff AS; Bom VJ; de Vries-Hospers HG; van Ingen J; vd Meer J; Hazenberg BP; Mulder PO; Weits J
Crit Care Med; 1992 Feb; 20(2):185-92. PubMed ID: 1371097
[TBL] [Abstract][Full Text] [Related]
9. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.
Hack CE; Ogilvie AC; Eisele B; Eerenberg AJ; Wagstaff J; Thijs LG
Intensive Care Med; 1993; 19 Suppl 1():S19-28. PubMed ID: 8053997
[TBL] [Abstract][Full Text] [Related]
10. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients.
Tateishi Y; Oda S; Nakamura M; Watanabe K; Kuwaki T; Moriguchi T; Hirasawa H
Shock; 2007 Nov; 28(5):549-53. PubMed ID: 18075483
[TBL] [Abstract][Full Text] [Related]
11. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury.
Donnelly TJ; Meade P; Jagels M; Cryer HG; Law MM; Hugli TE; Shoemaker WC; Abraham E
Crit Care Med; 1994 May; 22(5):768-76. PubMed ID: 8181284
[TBL] [Abstract][Full Text] [Related]
12. Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock.
Krafte-Jacobs B; Bock GH
Crit Care Med; 1996 Sep; 24(9):1455-9. PubMed ID: 8797615
[TBL] [Abstract][Full Text] [Related]
13. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection.
Groeneveld AB; Tacx AN; Bossink AW; van Mierlo GJ; Hack CE
Clin Immunol; 2003 Feb; 106(2):106-15. PubMed ID: 12672401
[TBL] [Abstract][Full Text] [Related]
14. Prognostic values of serum cytokines in septic shock.
Martin C; Saux P; Mege JL; Perrin G; Papazian L; Gouin F
Intensive Care Med; 1994; 20(4):272-7. PubMed ID: 8046121
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inflammatory cytokine concentration and physiologic parameters in septic shock.
Liaw YS; Yu CJ; Wu HD; Yang PC
J Formos Med Assoc; 1997 Sep; 96(9):685-90. PubMed ID: 9308320
[TBL] [Abstract][Full Text] [Related]
16. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
Lin WC; Chen CW; Chao L; Chao J; Lin YS
PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
[TBL] [Abstract][Full Text] [Related]
18. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
[TBL] [Abstract][Full Text] [Related]
19. Chronological changes in the complement system in sepsis.
Nakae H; Endo S; Inada K; Yoshida M
Surg Today; 1996; 26(4):225-9. PubMed ID: 8727941
[TBL] [Abstract][Full Text] [Related]
20. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL
Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
